Proprietary Technology. AMS represents that it does not have any rights to proprietary technology or intellectual property arising out of the Sponsored Research Agreement dated January 1, 1996 between AMS and Children's Hospital ("Children's"). AMS agrees that Reprogenesis may negotiate directly with Children's to acquire any such technology or intellectual property. Reprogenesis and AMS acknowledge that after January 26, 1999, AMS will no longer provide financial support for the patent prosecution of applications filed by Children's relating to inventions made during the term of the Sponsored Research Agreement.
Appears in 2 contracts
Sources: Termination and Release Agreement (Curis Inc), Termination and Release Agreement (Curis Inc)